Male androgenetic alopecia

    Deepani Rathnayake, Rodney Sinclair
    Image of study
    TLDR Hair loss in men treated best with early medication or transplant, new treatments researched.
    This document discusses male androgenetic alopecia (MAA), a genetic condition that causes hair loss in men. It affects up to 80% of males by the age of 80 and causes reduced self-esteem, loss of confidence, and anxiety in affected men. Hair transplant remains the only viable treatment for advanced hair loss, but newer agents such as prostaglandin analogues, gene therapy, and angiogenic growth factors are targets for future research. Effective and safe medications are available for the treatment of androgenetic alopecia, including topical minoxidil and finasteride tablets, which are FDA approved for the treatment of hair loss. Early treatment achieves the best results.
    View this study on tandfonline.com →

    Cited in this study

    Related

      Male androgenetic alopecia

      research Male androgenetic alopecia

      100 citations ,   May 2010 in “Expert Opinion on Pharmacotherapy”
      Hair loss in men treated best with early medication or transplant, new treatments researched.

      research Therapy of alopecia

        January 2005 in “Farmaceutski glasnik”
      The document discussed the psychological impact of hair loss and its significance to the pharmaceutical and cosmetic industries. Androgenetic alopecia, responsible for 95% of hair loss, was primarily linked to aging, heredity, and testosterone levels. Key treatments included minoxidil, which promoted hair growth through vasodilatation, and finasteride, which inhibited the conversion of testosterone to dihydrotestosterone, preventing hair follicle miniaturization. Other substances like Saw palmetto, emu oil, vitamin B6, Polysorbate 80, retinoic acid, and azelaic acid were also noted for their potential benefits. Additionally, drugs with antiandrogen properties such as cyproterone, spironolactone, cimetidine, and ketoconazole, along with treatments involving zinc, unsaturated fatty acids, immunosuppressive drugs, irritants, and PUVA, were mentioned as useful in certain cases.
      CLINICAL UPDATES IN HAIR

      research CLINICAL UPDATES IN HAIR

      19 citations ,   January 1997 in “Dermatologic Clinics”
      Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.